Family · Pharmaceutical analytical standards
Metoprolol
A cardioselective beta blocker synthesised in Sweden in 1969 and on the market since 1975: it slows the heart and reduces its workload, and is used for high blood pressure, angina, arrhythmias and heart failure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?To find it, Swedish researchers Bengt Åblad and Enar Carlsson synthesised and screened about 400 substances, looking for a beta blocker that would act mainly on the heart.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
